Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights
-
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
-
Damon Motors Inc. Completes Business Combination with Grafiti Holding Inc.
-
Maxim Group Reiterates Hold Rating on Aethlon Medical (AEMD)
-
Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States
-
A SPAC III Acquisition Corp. Announces Closing of $55 Million Initial Public Offering
-
B2i Digital Announced as Marketing Partner for ROTH's 13th Annual Technology Conference
-
B2i Digital Announced as Marketing Partner for ROTH’s 13th Annual Technology Conference
-
Microstrategy, Inc. (MSTR) Announces BTC and ATM Activity
-
MicroStrategy Announces BTC and ATM Activity; Raised $2.03 billion; Purchased 27,200 BTC; Now Holds 279,420 BTC with BTC Yield of 26.4% YTD
-
MacKenzie Realty Capital, Inc. Announces Listing on Nasdaq
-
A SPAC III Acquisition Corp. Announces Pricing of $55 Million Initial Public Offering
-
NioCorp Provides Preliminary Financial Results for the Three Months Ended September 30, 2024
-
NioCorp Announces Closing of Underwritten Public Offering
-
Kazia Therapeutics (KZIA) Granted Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib
-
Kazia Therapeutics Announces Granting of Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma Multiforme
-
NioCorp Announces Pricing of Approximately $6.0 Million Underwritten Public Offering & Concurrent Private Placement of Common Shares and Warrants
-
NioCorp Announces Commencement of Proposed Underwritten Public Offering of Common Shares & Warrants
-
Cullen/Frost Bankers (CFR) PT Raised to $149 at Maxim Group
-
Amazon.com (AMZN) PT Raised to $260 at Maxim Group
-
Apple (AAPL) PT Raised to $215 at Maxim Group
-
Apple offers modest growth outlook after iPhone sales help beat profit expectations
-
SRIVARU (SVMH) Announces Closing of Upsized $6.8 Million Underwritten Public Offering
-
Intelligent Bio Solutions (INBS) Partners with B2i Digital to Amplify Investor Outreach
-
Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach
-
Emerald Expositions Events (EEX) PT Lowered to $8 at Maxim Group
-
ALT5 Sigma Corporation Announces Participation at the Spartan Capital Investor Conference
-
SRIVARU Holding (SVMH) Prices 106.25M Unit Offering at $0.064/unit
-
SRIVARU (SVMH) Announces Pricing of Upsized $6.8 Million Underwritten Public Offering
-
Brainstorm Cell Therapeutics (BCLI) PT Lowered to $10 at Maxim Group
-
Lending Club (LC) PT Raised to $19 at Maxim Group
-
TuanChe (TC) Prices 761.72K Share Offering at $1.45/sh
-
TuanChe Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement
-
Maxim Group Downgrades PainReform Ltd. (PRFX) to Hold
-
WISeKey (WKEY) Enters Into $30 Million Convertible Notes Subscription Agreements
-
WISeKey Enters Into $30 Million Convertible Notes Subscription Agreements
-
WISeKey Enters Into $30 Million Convertible Notes Subscription Agreements
-
TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
-
Jet.AI (JTAI) Prices 15.6M Share Offering at $0.096/sh
-
Jet.AI Announces Pricing of $1.5 Million Registered Direct Offering
-
Nicolet Bankshares (NIC) PT Raised to $124 at Maxim Group
-
Maxim Group Downgrades Helius Medical Tech (HSDT) to Hold
-
Maxim Group Starts GameSquare Holdings Inc (GAME) at Buy
-
PetVivo Holdings, Inc. Announces Participation at The Spartan Capital Investor Conference Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement
-
The Nuvo Group is Recognized as a B2i Digital Featured Expert
-
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
-
Rani Therapeutics (RANI) Prices $10M Share and Warrant Offering at $3/sh, Cancels Certain Existing Warrants
-
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants
-
Maxim Group Starts Ocugen, Inc. (OCGN) at Buy
-
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

